Surprisingly, the analysis of CD8+ T cell subtypes revealed a significant increase in intra-tumor NK1.1+ CD8+ T cell infiltration after anti-CTLA4 Ab and combination therapy, unveiling a novel anti-CTLA4 Ab-dependent anti-tumor mechanism. This evidence concerns the gene CD8A and neoplasm.